07Jan
DEAL WATCH: End-of-Year Biosimilar Agreements
Following the string of biosimilar agreements announced in early November, a number of additional transactions were announced in early December, bringing 2019 to a roaring close with global biosimilars deals. On December 1, 2019, Luye Pharma Group...
By:
Goodwin
Related
Citing judicial criticism, as well as the original Supreme Court decisions on the issue, the NLRB sw...
Read More >
In late June, thirty-nine cities and counties advancing claims in the opioid multidistrict litigatio...
Read More >
All of us are, of course, concerned about what “Coronavirus Disease 2019” (COVID-19) will mean for...
Read More >
On March 27, 2020, the New York State Department of Economic Development d/b/a Empire State Developm...
Read More >
The IRS recently amended the rules applicable to hardship distributions from 401(k) and 403(b) plans...
Read More >
“Employer securities” in retirement plans have been the source of a significant amount of litigati...
Read More >